MORE►
biomarkers
Panna Sharma, CEO of Lantern Pharma
Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development
by Alex Edwards | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
by Sandra Chapman |
Feb 16, 2016
The pursuit of lasting brain health is one of the most exciting and urgent challenges facing humanity. Brain health among military service members is being called into question. Advanced reasoning skills in American students are falling behind those of other developed countries. Depression is estimated to cause 200 million lost workdays each year at a cost of $17 to $44 billion to employers....
MORE►
